IPSEN, OOO
- Country
- 🇷🇺Russia
- Ownership
- -
- Established
- 1929-01-01
- Employees
- 5.7K
- Market Cap
- $9.8B
- Website
- https://www.ipsen.com/
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 22
- Registration Number
- NCT00824512
- Locations
- 🇫🇷
Hospital Necker Enfants Malades, Paris, France
Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions
- Conditions
- Interventions
- First Posted Date
- 2008-12-24
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 49
- Registration Number
- NCT00814346
- Locations
- 🇫🇷
Hôpital Corentin Celton 4 parvis Corentin Celton, Issy-Les-Moulineaux, France
🇫🇷Hôpital de Juvisy, Juvisy sur Orge, France
🇫🇷Observatoire de l'âge, Paris, France
BN83495 in Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 17
- Registration Number
- NCT00790374
- Locations
- 🇺🇸
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
🇺🇸Johns Hopkins University Medical Center, Baltimore, Maryland, United States
🇺🇸Duke University Medical Center United States, Durham, North Carolina, United States
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 115
- Registration Number
- NCT00774930
- Locations
- 🇺🇸
VA Greater Los Angeles Health Care System, Los Angeles, California, United States
🇿🇦Westridge Medical Centre, Durban, South Africa
🇺🇦Medical Centre "Mriya", Kyiv, Ukraine
IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex
- Conditions
- Interventions
- First Posted Date
- 2008-09-05
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 1378
- Registration Number
- NCT00747604
- Locations
- 🇺🇸
Ipsen Central Contact, Basking Ridge, New Jersey, United States
Non Interventional Post Marketing Programme in Acromegaly
- Conditions
- First Posted Date
- 2008-09-05
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 42
- Registration Number
- NCT00747500
- Locations
- 🇬🇧
University Hospital Coventry & Warwickshire, Coventry, United Kingdom
🇬🇧Aberdeen Royal Infirmary, Aberdeen, United Kingdom
🇬🇧Barnsley General Hospital, Barnsley, United Kingdom
Non Interventional Post Marketing Programme in Neuroendocrine Tumours
- Conditions
- First Posted Date
- 2008-09-05
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 40
- Registration Number
- NCT00747786
- Locations
- 🇬🇧
University Hospital of Wales, Cardiff, United Kingdom
🇬🇧Aintree University Hospital, Liverpool, United Kingdom
🇬🇧Royal Free Hospital, London, United Kingdom
Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
- Conditions
- Interventions
- First Posted Date
- 2008-08-07
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 111
- Registration Number
- NCT00729313
- Locations
- 🇫🇷
Hôpital Nord, Marseille, France
🇫🇷CHU J. Minjoz, Besançon, France
🇫🇷Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)
- Conditions
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 275
- Registration Number
- NCT00710307
- Locations
- 🇫🇷
Ipsen Central Contact, Paris, France
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 124
- Registration Number
- NCT00701363
- Locations
- 🇷🇴
University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania
🇬🇷Polykliniki Hospital - Department of Endocrinology, Athens, Greece
🇬🇷B IKA Panagia Hospital - Department of Endocrinology, Thessaloniki, Greece